Merck

@Merck

We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only. FLS: merck.us/3TKXNuZ

Rahway, NJ

Joined April 2009

Merck
@Merck
Aug 19
In collaboration with @moderna_tx, we’re excited to share the first positive Phase 3 topline results for our investigational individualized neoantigen therapy (INT) in combination with our company’s immunotherapy in the adjuvant setting for certain patients with completely
00:00
Merck
@Merck
Aug 6
We’re pleased to announce the FDA has accepted our filing related to #RSV disease. Learn more: go.merck.com/~dti
Merck
@Merck
Aug 4
Join us today at 9 a.m. ET to learn more about our Q2 2026 #earnings: go.merck.com/~ea2 $MRK
00:00
Merck
@Merck
Aug 4
Our Q2 2026 #earnings results are live: go.merck.com/~2q6 Swipe below for perspective from Chairman and CEO Rob Davis. $MRK
Merck
@Merck
Jul 24
Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it
00:00